Skip to main navigation
Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • Home
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research Pipeline
      • Clinical Trials
    • Investor Relations

      • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historical Price Lookup
        • Investment Calculator
        • Analyst Coverage
      • Financial Information
        • SEC Filings
        • Financial Reports
        • Quarterly Results
      • Corporate Governance
        • Governance Highlights
        • Management Team
        • Board of Directors
        • Committee Composition
        • Annual General Meeting
      • Shareholder Services
        • Investor FAQs
        • Information Request
        • E-mail Alerts
        • IR Contacts
    • Contact Us
646.449.1830

Breadcrumb

  1. Home
  2. Investors
  3. SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group Downloads
09/14/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009709.rtf
0001179110-20-009709.xls
0001179110-20-009709.pdf
09/01/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009461.rtf
0001179110-20-009461.xls
0001179110-20-009461.pdf
09/01/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009462.rtf
0001179110-20-009462.xls
0001179110-20-009462.pdf
08/28/20 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-20-100190.rtf
0001104659-20-100190.xls
0001104659-20-100190.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/20/20 8-K/A

Amendment to a previously filed 8-K

Current Reports
0001104659-20-097315.rtf
0001104659-20-097315.xls
0001104659-20-097315.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/17/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009083.rtf
0001179110-20-009083.xls
0001179110-20-009083.pdf
08/17/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009084.rtf
0001179110-20-009084.xls
0001179110-20-009084.pdf
08/17/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009086.rtf
0001179110-20-009086.xls
0001179110-20-009086.pdf
08/14/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009054.rtf
0001179110-20-009054.xls
0001179110-20-009054.pdf
08/13/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009024.rtf
0001179110-20-009024.xls
0001179110-20-009024.pdf
08/13/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009023.rtf
0001179110-20-009023.xls
0001179110-20-009023.pdf
08/11/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-008893.rtf
0001179110-20-008893.xls
0001179110-20-008893.pdf
08/11/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-008892.rtf
0001179110-20-008892.xls
0001179110-20-008892.pdf
08/11/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-008889.rtf
0001179110-20-008889.xls
0001179110-20-008889.pdf
08/11/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-008890.rtf
0001179110-20-008890.xls
0001179110-20-008890.pdf
08/11/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-008891.rtf
0001179110-20-008891.xls
0001179110-20-008891.pdf
08/10/20 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-20-092424.rtf
0001104659-20-092424.xls
0001104659-20-092424.pdf
08/10/20 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
0001012477-20-000013.rtf
0001012477-20-000013.xls
0001012477-20-000013.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/06/20 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-20-091513.rtf
0001104659-20-091513.xls
0001104659-20-091513.pdf
07/13/20 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-20-082927.rtf
0001104659-20-082927.xls
0001104659-20-082927.pdf

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Tools

  • Print Page
  • RSS
  • E-mail Alerts

Investor Relations

  • Investors
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Annual General Meeting
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
http://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com/

© COPYRIGHT AVADEL PHARMACEUTICALS, PLC. ALL RIGHTS RESERVED

0117 AVL WBST MAIN_KP2